Sedative-hypnotic Co-prescribing with Opioids in a Large Network of Community Health Centers.

ABSTRACT:

Objective

When prescribed with opioids, sedative-hypnotics substantially increase the risk of overdose. The objective of this paper was to describe characteristics and trends in opioid sedative-hypnotic co-prescribing in a network of safety-net clinics serving low-income, publicly insured, and uninsured individuals.

Methods

This retrospective longitudinal analysis of prescription orders examined opioid sedative-hypnotic co-prescribing rates between 2009 and 2018 in the OCHIN network of safety-net community health centers. Sedative-hypnotics included benzodiazepine and non-benzodiazepine sedatives (eg, zolpidem). Co-prescribing patterns were assessed overall and across patient demographic and co-morbidity characteristics.

Results

From 2009 to 2018, 240 587 patients had

SUBMITTER: Hartung DM 

PROVIDER: S-EPMC9834924 | biostudies-literature | 2023 Jan-Dec

REPOSITORIES: biostudies-literature